Cargando…
Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development
Advancement in novel target detection using improved molecular cancer biology has opened up new avenues for promising anti-cancer drug development. In the past two decades, the mechanism of tumor hypoxia has become more understandable with the discovery of hypoxia-inducible factor-1α (HIF-1α). It is...
Autores principales: | Ghosh, Rituparna, Samanta, Priya, Sarkar, Rupali, Biswas, Souradeep, Saha, Prosenjit, Hajra, Subhadip, Bhowmik, Arijit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413992/ https://www.ncbi.nlm.nih.gov/pubmed/36014432 http://dx.doi.org/10.3390/molecules27165192 |
Ejemplares similares
-
In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
por: Bhowmik, Arijit, et al.
Publicado: (2021) -
HIF 1 α – a promising target for the treatment of meningiomas
por: Butta, Shristi, et al.
Publicado: (2023) -
Are Natural Compounds a Promising Alternative to Synthetic Cross-Linking Agents in the Preparation of Hydrogels?
por: Sapuła, Paulina, et al.
Publicado: (2023) -
Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
por: Rehman, Zaira, et al.
Publicado: (2019) -
Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies
por: Pal, Dilipkumar, et al.
Publicado: (2023)